Genitourinary Syndrome of Menopause (GSM): The Condition Affecting Most Women That Almost No One Talks About
It’s not “just dryness.” It’s not normal aging. And it is treatable.
What is GSM?
Genitourinary Syndrome of Menopause (GSM) is a condition caused by declining estrogen levels during perimenopause and menopause that affects the vaginal, vulvar, and urinary tissues. Symptoms include vaginal dryness, pain with intercourse, urinary urgency, and recurrent UTIs. Between 50–70% of postmenopausal women experience GSM, yet only 20–30% ever receive treatment — often because symptoms go unreported and providers don’t ask. GSM is not a normal part of aging that must be endured. It is a medical condition with effective treatments available
We need to talk about something that affects the majority of women going through menopause — and that the majority of those women have never discussed with a doctor.
Not because it isn’t serious. Not because there are no options. But because no one asked. Because it felt embarrassing to bring up. Because somewhere along the way, women learned to quietly absorb symptoms that were quietly stealing from their quality of life.
This is Part 8 of The Midlife Conversations We Should Have Started 20 Years Ago — and today we’re talking about Genitourinary Syndrome of Menopause, or GSM.
What Is GSM?
Genitourinary Syndrome of Menopause is the medical term for a collection of symptoms that occur when estrogen levels decline during perimenopause and menopause. The tissues of the vagina, vulva, and urinary tract are highly sensitive to estrogen — and when those levels drop, these tissues begin to thin, dry out, and lose elasticity.
The result is a constellation of symptoms that women are often told are just “part of getting older”:
- Vaginal dryness and irritation
- Pain or discomfort during intercourse
- Urinary urgency or frequency
- Recurrent urinary tract infections (UTIs)
- Burning or itching in the vulvar area
- Feeling of pressure or discomfort
- Light bleeding after intercourse
What makes GSM particularly difficult is that many of these symptoms — the UTIs, the urinary urgency, the irritation — don’t obviously announce themselves as hormonal. Women often spend years cycling through treatment for individual symptoms without anyone connecting them to a single underlying cause: estrogen deficiency.
The Numbers Tell an Uncomfortable Story
50–70% of postmenopausal women experience GSM symptoms. Yet only 20–30% ever receive treatment.
That gap — between how many women are affected and how many receive care — is not a patient failure. It is a systems failure.
Research consistently shows that many women don’t report their symptoms at all. When asked why, the answers are familiar:
They thought it was normal aging. They were embarrassed. Nobody asked.
And so the actual untreated rate is almost certainly higher than the data suggests — because the data only captures the women who said something.
Why Wasn’t Anyone Told About This?
Most women were never told that vaginal dryness, urinary symptoms, pain with intimacy, and recurrent UTIs could all be connected. They were never told this was driven by hormonal changes. They were never told it was treatable.
And even now, the conversation is limited. GSM is often dismissed as a cosmetic concern or a minor inconvenience — rather than a medical condition that affects confidence, relationships, and daily quality of life.
This isn’t a niche issue. It is one of the most common and most undertreated conditions in women’s health.
.
What Does Treatment Look Like?
The good news is that GSM responds well to treatment, particularly when addressed early. Options range from local hormonal therapies — which work directly on the tissue with minimal systemic absorption — to non-hormonal moisturizers and lubricants, to laser-based treatments for women who cannot use hormones.
What matters most is this: you do not have to just live with it.
It’s also worth noting honestly that while short-term treatment data is encouraging, long-term outcomes research beyond one year remains limited and inconsistent. This is an area where women deserve more research, more clarity, and more ongoing conversation with a physician who specializes in this phase of life — not a five-minute mention at an annual exam.
The Conversation That Should Have Happened Decades Ago
We should have been talking about this 20 years ago. We should have been teaching women what to expect from their bodies during this transition — not just about hot flashes and missed periods, but about the quieter, more private ways that hormonal change shows up.
We weren’t.
So we start now. In my practice at ThriveWellMD, these are the conversations I have with every patient navigating perimenopause and menopause. Not because they’re uncomfortable — but because you deserve a physician who asks, who listens, and who knows that these symptoms are connected, treatable, and worth addressing.
If any of this resonates, you don’t have to figure it out alone.
These are the conversations ThriveWellMD was built for.
If you’re navigating perimenopause or menopause and no one has asked you the right questions yet — let’s change that. Book a free 15-minute physician consult. Available via telehealth in GA, FL, NC, SC, IA, TX & WA
